Clinical Trial Update: A Study of Emapalumab for Pediatric Aplastic Anemia [Phase 2]

View source ↗

Summary

A Phase 2 pediatric study evaluating emapalumab for aplastic anemia is currently recruiting, aiming to assess safety and potential efficacy in children with hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• GAMIFANT (emapalumab-lzsg)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Aplastic Anemia, Cytopenia | Phase 2 | Status: RECRUITING